Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Palecek

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Vnitrni Lekarstvi|May 3, 2007
[Pulmonary hypertension in Takayasu arteritis]M Skvarilová, J Lindner, B Hanzová, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|May 14, 2010
Fabry disease - Vascular manifestationsD Karetova, J Bultas, G Dostalova, et al.
Vnitrni Lekarstvi|June 21, 2007
[Long-term experience with trerpostinil infusion treatment in patients with pulmonary arterial hypertension in the Czech Republic]P Jansa, D Ambroz, J Maresová, et al.
Casopis Lekaru Ceskych|July 29, 2005
[Takotsubo cardiomyopathy: case report and literature review]T Palecek, A Linhart, P Jansa, et al.
Journal of Inherited Metabolic Disease|January 5, 2002
Cardiac manifestations in Fabry diseaseA Linhart, J C Lubanda, T Palecek, et al.
Vnitrni Lekarstvi|November 18, 2008
[The isolated form of cardiac amyloidosis in the form of beginning infiltrative cardiomyopathy without restrictive physiology]P Kuchynka, T Palecek, S Simek, et al.
Herz|December 17, 2016
Utility of cardiac CT for evaluating delayed contrast enhancement in dilated cardiomyopathyV Cerny, P Kuchynka, J Marek, et al.
Herz|November 18, 2017
Plasma osteopontin levels in patients with dilated and hypertrophic cardiomyopathyJ Podzimkova, T Palecek, P Kuchynka, et al.
Vnitrni Lekarstvi|May 6, 2003
[Comparison of the cost effectiveness of treatment of acute myocardial infarct with primary angioplasty and thrombolysis ]L Golán, S Simek, A Linhart, et al.
Herz|July 11, 2019
Plasma osteopontin levels, but not its myocardial expression, reflect heart failure severity in recently diagnosed dilated cardiomyopathyJ Podzimkova, T Palecek, P Kuchynka, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Vnitrni Lekarstvi|May 3, 2007
[Pulmonary hypertension in Takayasu arteritis]M Skvarilová, J Lindner, B Hanzová, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|May 14, 2010
Fabry disease - Vascular manifestationsD Karetova, J Bultas, G Dostalova, et al.
Vnitrni Lekarstvi|June 21, 2007
[Long-term experience with trerpostinil infusion treatment in patients with pulmonary arterial hypertension in the Czech Republic]P Jansa, D Ambroz, J Maresová, et al.
Casopis Lekaru Ceskych|July 29, 2005
[Takotsubo cardiomyopathy: case report and literature review]T Palecek, A Linhart, P Jansa, et al.
Journal of Inherited Metabolic Disease|January 5, 2002
Cardiac manifestations in Fabry diseaseA Linhart, J C Lubanda, T Palecek, et al.
Vnitrni Lekarstvi|November 18, 2008
[The isolated form of cardiac amyloidosis in the form of beginning infiltrative cardiomyopathy without restrictive physiology]P Kuchynka, T Palecek, S Simek, et al.
Herz|December 17, 2016
Utility of cardiac CT for evaluating delayed contrast enhancement in dilated cardiomyopathyV Cerny, P Kuchynka, J Marek, et al.
Herz|November 18, 2017
Plasma osteopontin levels in patients with dilated and hypertrophic cardiomyopathyJ Podzimkova, T Palecek, P Kuchynka, et al.
Vnitrni Lekarstvi|May 6, 2003
[Comparison of the cost effectiveness of treatment of acute myocardial infarct with primary angioplasty and thrombolysis ]L Golán, S Simek, A Linhart, et al.
Herz|July 11, 2019
Plasma osteopontin levels, but not its myocardial expression, reflect heart failure severity in recently diagnosed dilated cardiomyopathyJ Podzimkova, T Palecek, P Kuchynka, et al.
Pageof 3